{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-042237","form_type":"8-K","ticker":"VIR","cik":"0001706431","company_name":"Vir Biotechnology, Inc.","filed_at":"2026-06-10T20:27:32+00:00","discovered_at":"2026-06-10T20:28:00.318452+00:00","generated_at":"2026-06-10T20:29:58.849423+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Vir Biotechnology appoints Timothy Coughlin as new director and Audit Committee Chair","bullets":["Board increased from 7 to 8 members; Timothy Coughlin appointed effective June 9, 2026.","Coughlin named Chair of the Audit Committee immediately upon appointment.","Will receive standard non-employee director cash and equity per company policy; no related-party transactions.","Received automatic stock option and RSU awards under the 2019 Equity Incentive Plan."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-042237","json":"https://secwatch.observer/filing/0001628280-26-042237.json","markdown":"https://secwatch.observer/filing/0001628280-26-042237.md","text":"https://secwatch.observer/filing/0001628280-26-042237.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042237/0001628280-26-042237-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042237/vir-20260609.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T20:29:58.849423+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65fe82a6c8","claim":"Timothy Coughlin was appointed as Director and Chair of the Audit Committee at Vir Biotechnology, Inc..","evidence_excerpt":"the appointment of Timothy Coughlin, CPA, to fill the newly created vacancy and serve on the Board as a Class III director until the Company's 2028 annual meeting of stockholders, as well as the appointment of Mr. Coughlin as Chair of the Audit Committee of the Board, in each case effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042237/0001628280-26-042237-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director and Chair of the Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}